Clinical Trials Browser

Phase 2 × Carcinoma, Pancreatic Ductal × S 1 (combination) × Clear all

NCT03403101 2021-04-09

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Carcinoma, Pancreatic Ductal